These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17290507)

  • 1. PALB2-new breast-cancer susceptibility gene.
    Simpson S
    Lancet Oncol; 2007 Feb; 8(2):105. PubMed ID: 17290507
    [No Abstract]   [Full Text] [Related]  

  • 2. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
    Rahman N; Seal S; Thompson D; Kelly P; Renwick A; Elliott A; Reid S; Spanova K; Barfoot R; Chagtai T; Jayatilake H; McGuffog L; Hanks S; Evans DG; Eccles D; ; Easton DF; Stratton MR
    Nat Genet; 2007 Feb; 39(2):165-7. PubMed ID: 17200668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.
    Obermeier K; Sachsenweger J; Friedl TW; Pospiech H; Winqvist R; Wiesmüller L
    Oncogene; 2016 Jul; 35(29):3796-806. PubMed ID: 26640152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
    Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
    Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
    Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
    Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PALB2 gene increases breast cancer risk.
    Tanday S
    Lancet Oncol; 2014 Sep; 15(10):e423. PubMed ID: 25328949
    [No Abstract]   [Full Text] [Related]  

  • 7. PALB2 mutations and breast-cancer risk.
    Evans MK; Longo DL
    N Engl J Med; 2014 Aug; 371(6):566-8. PubMed ID: 25099582
    [No Abstract]   [Full Text] [Related]  

  • 8. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
    Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
    Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PALB2/FANCN: recombining cancer and Fanconi anemia.
    Tischkowitz M; Xia B
    Cancer Res; 2010 Oct; 70(19):7353-9. PubMed ID: 20858716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants in the PALB2 gene confer susceptibility to breast cancer: a meta-analysis.
    Zhang YX; Wang XM; Kang S; Li X; Geng J
    Asian Pac J Cancer Prev; 2013; 14(12):7149-54. PubMed ID: 24460267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
    Jones S; Hruban RH; Kamiyama M; Borges M; Zhang X; Parsons DW; Lin JC; Palmisano E; Brune K; Jaffee EM; Iacobuzio-Donahue CA; Maitra A; Parmigiani G; Kern SE; Velculescu VE; Kinzler KW; Vogelstein B; Eshleman JR; Goggins M; Klein AP
    Science; 2009 Apr; 324(5924):217. PubMed ID: 19264984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
    Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
    Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against PALB2 involvement in Icelandic breast cancer susceptibility.
    Gunnarsson H; Arason A; Gillanders EM; Agnarsson BA; Johannesdottir G; Johannsson OT; Barkardottir RB
    J Negat Results Biomed; 2008 Jul; 7():5. PubMed ID: 18637200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fanconi anemia and breast cancer susceptibility.
    Patel KJ
    Nat Genet; 2007 Feb; 39(2):142-3. PubMed ID: 17262024
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic predisposition to breast cancer: the next chapters.
    Boyd J
    Cancer; 2014 Apr; 120(7):932-4. PubMed ID: 24415404
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks.
    Hayakawa T; Zhang F; Hayakawa N; Ohtani Y; Shinmyozu K; Nakayama J; Andreassen PR
    J Cell Sci; 2010 Apr; 123(Pt 7):1124-30. PubMed ID: 20332121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.
    Ameziane N; van den Ouweland AM; Adank MA; Vijzelaar RN; Errami A; Dorsman JC; Joenje H; Meijers-Heijboer H; Waisfisz Q
    Breast Cancer Res Treat; 2009 Dec; 118(3):651-3. PubMed ID: 19504183
    [No Abstract]   [Full Text] [Related]  

  • 19. Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population.
    Cao AY; Yu KD; Yin WJ; Jin W; Di GH; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2010 Aug; 123(1):133-8. PubMed ID: 19921424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland.
    Kluska A; Balabas A; Piatkowska M; Czarny K; Paczkowska K; Nowakowska D; Mikula M; Ostrowski J
    BMC Med Genomics; 2017 Mar; 10(1):14. PubMed ID: 28279176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.